Quarterly Result7 Nov 2025, 07:25 pm
Innova Captab Ltd Reports 19.5% YoY Revenue Growth in Q2 FY26, Strengthens Manufacturing Capabilities
AI Summary
Innova Captab Limited, a leading pharmaceutical company, has announced its financial results for the quarter and half year ending September 30, 2025. The company reported a revenue from operations of X 380.4 crores in Q2 FY26, representing a YoY growth of 19.5%. EBITDA for the quarter was X 56.1 crores. The company's manufacturing capabilities were strengthened with the successful inspection of its Cephalosporin plant in Baddi by the UK-MHRA and of its Jammu facility by the State Service of Ukraine on Medicines and Drugs Control (SMDC).
Key Highlights
- Revenue from Operations registered a YoY growth of 19.5% in Q2 FY26
- EBITDA for Q2 FY26 was X 56.1 crores
- Manufacturing capabilities strengthened with successful inspections by UK-MHRA and SMDC
- H1 FY26 revenues totalled to X 731.9 crores
- Profit after tax in H1 FY26 was X 60.7 crores